Capillary Electrophoresis Market Expected to Hit US$ 611.25 Million by 2033 as Demand for Advanced Biomolecule Analysis Accelerates

DataM Intelligence has released a new research report titled "Capillary Electrophoresis Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Capillary Electrophoresis Market.

Get a Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/capillary-electrophoresis-market?ram

The Global Capillary Electrophoresis Market reached US$ 349.70 million in 2023, with a rise to US$ 368.21 million in 2024, and is expected to reach US$ 611.25 million by 2033, growing at a CAGR of 5.8% during the forecast period 2025-2033.

The market is witnessing significant growth due to the increasing adoption of capillary electrophoresis technologies in pharmaceutical research, biotechnology, clinical diagnostics, and genomics applications. Rising demand for precise biomolecule separation, expanding proteomics and nucleic acid analysis, and advancements in automated analytical systems are further strengthening market expansion globally.

Industry participants are increasingly focusing on high-throughput and cost-efficient capillary electrophoresis platforms that improve analytical accuracy, reduce sample processing time, and support complex biological testing workflows. Growing investments in personalized medicine, drug discovery, and advanced laboratory infrastructure are expected to create long-term opportunities for manufacturers, research institutions, and diagnostic laboratories operating in this market.

Key Industry Developments

United States:
✅ March 2026: SCIEX published new technical advancements focused on improving peak resolution in capillary electrophoresis workflows, highlighting optimized charge-zone separation and enhanced electroosmotic flow control for biopharma and proteomics applications. The development strengthened CE assay reproducibility and analytical sensitivity for complex biomolecule characterization in pharmaceutical laboratories.

✅ September 2025: SCIEX launched native fluorescence detection capabilities for its BioPhase 8800 system at CE Pharm 2025, significantly enhancing protein-based capillary electrophoresis assays. The innovation improved sensitivity for biologics analysis and reinforced the company's leadership in automated CE systems for advanced biopharmaceutical research.

✅ July 2025: Agilent Technologies introduced upgraded LC & CE instrument driver releases designed to improve integration, automation, and software compatibility for capillary electrophoresis laboratories. The updates enhanced workflow standardization and enabled broader interoperability with chromatography data systems used in regulated analytical environments.

Japan:
✅ October 2025: Shimadzu Corporation expanded promotion of its MultiNA microchip electrophoresis platform for automated DNA/RNA analysis, targeting faster genomic and mutation-check workflows in clinical and research laboratories. The system supported high-throughput sample processing with improved sensitivity and lower operational costs compared with conventional gel electrophoresis methods.

✅ August 2025: Shimadzu Corporation received international Red Dot Design Award 2025 recognition for its MultiNA II Microchip Electrophoresis System, highlighting technological innovation and workflow efficiency in nucleic acid analysis. The recognition strengthened Shimadzu's position in automated electrophoresis solutions for life-science and molecular diagnostics applications.

✅ June 2025: Shimadzu Corporation showcased expanded electrophoresis-linked proteomics and biomolecule analysis solutions through new application-focused research publications and analytical workflow developments. The company emphasized integration between electrophoresis systems and mass spectrometry platforms to improve protein characterization accuracy and laboratory productivity.

Strategic Acquisitions & Partnerships
✅ LICORbio - Acquisition
(July, 2025)
LICORbio officially announced the acquisition of SERVA Electrophoresis, a Germany-based provider of electrophoresis reagents, consumables, and workflow instrumentation. The acquisition expanded LICORbio's electrophoresis and protein analysis portfolio, enabling the company to offer integrated end-to-end workflows spanning sample preparation, separation, imaging, and quantification for life sciences research applications.

Key Players:
Thermo Fisher Scientific | Agilent Technologies | SCIEX | Bio-Rad Laboratories | Sebia

Key Highlights: Top 5 Key Players in Capillary Electrophoresis Market 2026
-Thermo Fisher Scientific: Expanded its capillary electrophoresis portfolio with the launch of the Applied Biosystems SeqStudio Flex Dx Genetic Analyzer, an IVDR-compliant system designed for Sanger sequencing and fragment analysis with enhanced workflow flexibility, smart connectivity, and automated sample prioritization for clinical laboratories.

-Agilent Technologies: Introduced the Agilent ProteoAnalyzer System, an automated parallel capillary electrophoresis platform developed to improve protein characterization workflows with higher throughput, simplified analysis, and enhanced efficiency for pharmaceutical and biotech research applications.

-SCIEX: Strengthened its capillary electrophoresis capabilities through advanced PA 800 Plus Pharmaceutical Analysis System solutions and high-resolution RNA integrity workflows, supporting biopharmaceutical analysis, nucleic acid characterization, and mRNA quality assessment for modern therapeutic development.

-Bio-Rad Laboratories: Enhanced its electrophoresis and bioseparation technologies with improved automated sample analysis workflows and integrated genomic research solutions, supporting clinical diagnostics, biomolecule separation, and precision laboratory testing applications.

-Sebia: Continued expanding its clinical capillary electrophoresis leadership through advanced automation platforms for protein electrophoresis and hemoglobin testing, delivering faster analytical performance, improved diagnostic accuracy, and streamlined laboratory operations for hospital and diagnostic laboratories.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/capillary-electrophoresis-market?ram

Main Drivers and Trends Shaping the Future of the Capillary Electrophoresis Market
-Precision Medicine Expansion: Rising adoption of personalized medicine and biomarker-based diagnostics is increasing demand for capillary electrophoresis systems in genomics, proteomics, and clinical research applications.

-Biopharmaceutical Growth: Expanding biologics and biosimilars production is driving the use of capillary electrophoresis for protein characterization, impurity profiling, and quality control in pharmaceutical manufacturing workflows.

-Technological Advancements: Automation, high-throughput analysis, microfluidic integration, and enhanced detection sensitivity are improving operational efficiency and encouraging adoption across research laboratories and diagnostic centers.

-Genetic and Forensic Applications: Growing utilization in DNA sequencing, forensic testing, and nucleic acid analysis is strengthening market demand, particularly with increasing investments in molecular diagnostics and life sciences research.

-Market Challenges: High instrument costs, complex sample preparation procedures, limited skilled professionals, and stringent regulatory validation requirements continue to restrain wider adoption, especially in small and mid-sized laboratories.

Regional Insights:
-North America: 38.05% (Largest share, driven by strong pharmaceutical & biotechnology R&D investments, advanced healthcare infrastructure, and high adoption of precision diagnostic technologies).

-Europe: 29.61% (Supported by increasing demand for molecular diagnostics, expanding biotechnology research, and rising adoption of automated analytical systems).

-Asia Pacific: 25.19% (Fastest growing region, fueled by rising healthcare investments, growing biotechnology industries in China, India, and Japan, and increasing genetic research activities).

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=capillary-electrophoresis-market?ram

Market Segmentation Analysis:
-By Product Type: Instruments and Consumables Drive Market Expansion
The market is segmented into instruments, consumables, and software. Instruments form the core of capillary electrophoresis systems, widely adopted in pharmaceutical, biotechnology, and academic laboratories for precise molecular separation and analysis. Consumables, including capillaries, reagents, buffers, and cartridges, witness consistent demand due to repetitive laboratory usage and recurring replacement cycles. Software solutions are increasingly integrated to support automated data acquisition, analysis, workflow management, and regulatory compliance, improving operational efficiency and accuracy in complex laboratory environments.

-By Mode of Capillary Electrophoresis: Capillary Zone Electrophoresis Leads Adoption
Capillary zone electrophoresis is extensively utilized for its simplicity, high resolution, and rapid separation capabilities in biomolecule analysis. Capillary gel electrophoresis is widely applied in DNA sequencing and protein characterization due to its superior fragment separation efficiency. Capillary electrochromatography combines electrophoretic and chromatographic techniques, offering enhanced selectivity for complex sample analysis. Other electrophoresis modes support specialized applications across clinical diagnostics, proteomics, and pharmaceutical research.

-By Application: Nucleic Acid and Protein Analysis Fuel Demand
Applications include nucleic acid analysis, protein analysis, genomic DNA, plasmid DNA, fragment analysis, RNA/mRNA analysis, and others. Nucleic acid analysis remains a major application area due to growing genomics and molecular diagnostics research. Protein analysis is expanding rapidly with increasing biologics and proteomics studies. Genomic DNA and plasmid DNA analysis support gene therapy and biotechnology advancements, while fragment and RNA/mRNA analysis gain momentum from precision medicine and vaccine development activities.

-By End User: Pharmaceutical and Research Institutes Remain Key Users
Research organizations and academic institutes extensively utilize capillary electrophoresis for genomics, proteomics, and biomolecular research activities. Pharmaceutical and biotechnology companies are major adopters due to rising drug discovery, biologics development, and quality control requirements. Clinical laboratories increasingly implement capillary electrophoresis technologies for disease diagnostics, genetic testing, and biomarker identification, supported by growing demand for accurate and high-throughput analytical techniques

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to provide swift and astute solutions to clients like you. We encompass a multitude of syndicated reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.